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ABSTRACT 
Plants are very potential & vital source for human health and also used therapeutically in the various kidney disorders due to prese nce of 
phytochemical constituents. There are numerous herbs existing that have more pharmacological activities including with nephroprotective 
activity. Now days herbal drugs are verified & proved as nephroprotective agents and used for improving renal health, even reverse renal 
damages. The current review is targeted to explain the Unani & modern concept of kidney disorders, nephrotoxicity and the list of scientifically 
proved medicinal plants having nephroprotective activity medicinal plants which used in the treatment of renal disorders.  
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INTRODUCTION:  
The waste products produced in the body due to various 
metabolic activities must be excreated from the body (1). If 
they are allowed to accumulate they are injurious to health 
(2). Kidney is an important organ of the body, which has a 
natural function of excretion of waste products from the 
body. Apart from this it controls the volume and composition 
of the body fluids, for water and virtually all electrolytes in 
the body, balance between intake and output is maintained 
in large part by the kidneys (3).. Kidneys are most important 
channel of excretion for majority of drugs and its metabolites 
(4), so it always opens up to receive the drugs and other 
toxins which cause renal damage or renal toxicity (5). 
Prominent Unani scholars were very much concern about 
renal disorders. Chronic kidney failure has been described in 
the classical Unani literature as zaufe Kuliya (6), (7), (8), (9), 
(10). In Unani System of medicine kidney diseases are 
caused due to three reasons; Su’i Mizaj-i- Kulya, Su’i 
Tarkeeb, Tafarruq wa Ittesal (11). There are a unique 
concept of muqawwiyat (tonics) in unani system of medicine. 
According to Ibn-e-Rushd (1980) functions of the kidney 
depends upon its Quwwa. Whenever any Quwwa becomes 
weak kidney disorders appear. These Quwwa are as follows, 
Quwwat-e-Hazima, Quwwat-e-Jaziba, Quwwat-e-Masika, 
Quwwat-e-Dafia, Quwwat-e-mumayyaza. (7). So herbal drugs 
are capable to tone up the kidney or other important organs 
as well as also provide strength to them. In modern medicine 
concept of kidney disorders can be defined as “a 
heterogeneous group of disorders which affected the kidney 
structure and its functions. Now a days, it is accepted that 
even minor abnormalities in measures of kidney structure 
and function are related with higher risk for other organ 
systems as well as mortality, all of which happen far more 
frequently than kidney failure. Acute & chronic kidney failure 
comes in the category of kidney disease which can be life 
threatening.  Reduction in GFR (Glomerular filtration rate) 
that decreases renal excretory functions is called as renal 
failure. This is convoyed to a changeable variable by failure 
of erythropoietin production, vitamin D hydroxylation, and 
regulation of acid-base balance, regulation of salt & water 
balance and blood pressure (12). Nephrotoxicity occurs 
when kidney-specific detoxification and excretion do not 
work properly due to the damage or destruction of kidney 
function by exogenous or endogenous toxicants (effect of 
toxic chemicals or drugs) (13), (14). Plants are very potential 
& vital source for human health and also used therapeutically 
in the various kidney disorders due to presence of 
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phytochemical constituents. There are numerous herbs 
existing that have more pharmacological activities including 
with nephroprotective activity. Now a days herbal drugs are 
verified & proved as nephroprotective agents and used for 
improving renal health, even reverse renal damages. The 
present review is aimed to elucidate the list of 
nephroprotective medicinal plants, which are scientifically 
proved in treating renal disorders. 
Unani Perspective of Kidney Diseases:  
According to Ibn-e-Rushd (1980) functions of the kidney 
depends upon its Quwwa. Whenever any Quwwa becomes 
weak kidney disorders appear. These Quwwa are as follows 
 Quwwat-e-Hazima 
 Quwwat-e-Jaziba 
 Quwwat-e-Masika 
 Quwwat-e-Dafia 
 Quwwat-e-mumayyaza 
In Unani System of medicine kidney diseases are caused due 
to three reasons; (15), (7); 
 Su’i Mizaj-i- Kulya 
 Su’i Tarkeeb 
 Tafarruq wa Ittesal 
1. Su’i Mizaj-i- Kulya (Renal dyscrasia): any alteration 
in temperament of kidney from normal called as Su’i 
Mizaj-i- Kulya. If alteration is found in blood (dam) or 
bile (safra) called as  Su’i Mizaj-i- Kulya Haar (Renal hot 
dyscrasia) and if alteration in phlegm (balgham) or 
black bile (sauda) known as Su’i Mizaj-i- Kulya Barid 
(Renal cold dyscrasia) due to this altered temperament 
there are following diseases found in kidney such as  
 Huzāl al-kulya (Reduction in the size of kidney or Renal 
hypotrophy) 
 Du’f al-Kulya (Weakness of kidney) 
 Dhayabitus Hārr (Diabetes Mellitus), Dhayabitus bārid 
(Diabetes Insipidus) 
 Hasāh al-kulya (Renal caculus) 
 Sudad al-kulya (Renal obstruction) 
 Waram al-kulya (Nephritis) 
 Dubayala al-kulya (Renal Abscess) 
2. Su’i Tarkeeb: any variation in the formation of kidney 
at the time of intra uterine life (abnormality in 
genome), Amraze shakal such as Marz Akyas-e Kulya 
(Polycystic kidney disease), Amraze miqdar such as 
Huzāl al-kulya (Renal hypotrophy), Amraze adad such 
as Renal agenesis. 
3. Tafarruq wa Ittesal (Renal Damage):  
 Quruh al-kulya (Renal ulcers) 
 Jarab al-kulya (Renal irritability) 
 Rih al-kulya  
 Waja’ al-kulya (Renal pain)
 
Amraaze Kulya (Renal Diseases), Causes, Sign & Symptoms (7), (16), (17) 
S. No. Name of the disease Causes Sign & Symptoms 
1 Huzāl al-kulya (Reduction in the size of 
kidney or Renal hypotrophy) 
 
Impaired temperament (hot or cold) of 
kidney 
Weakness of digestive faculties (Quvvate 
hazima) 
-Urine become colorless 
-Poly urea 
 
2 Du’f al-Kulya (Weakness of kidney) 
 
Impaired temperament 
Dilatation of calyces 
Excessive use of diuretics,  
More physical efforts.  
 
 
Frequency of  urine 
increases 
Oliguria 
Loss of libido 
Headache 
Heaviness 
3 Dhayabitus Hārr (Diabetes Mellitus), 
Dhayabitus bārid (Diabetes Insipidus) 
 
Impaired hot temperament 
Expulsive faculty (Quvvate da’fea) becomes 
strong & weakening of  holding faculty 
(Quvvate masika) 
Dilatation of calyces 
Excessive thirst  
Excessive  & colorless 
urination  
 
4 Hasāh al-kulya (Renal caculus) 
 
Retaining of Viscous humor inside the 
kidneys  
Weakening of expulsive faculty of kidney 
Any hindrance due to kidney’s impaired 
temperament  
Pain in lumber region 
associated with vomiting 
Frequency of urination 
increases 
Dysuria & anuria 
Colorless urination   
5 Sudad al-kulya (Renal obstruction) 
 
Accumulations of mucilaginous viscous 
humors   
Inflammations (Warm al-kulya)  
Pain with renal heaviness  
Decreased urine output 
Fever due to inflammation 
6 Waram al-kulya Hārr  (Acute Nephritis) 
 
Viscous blood (Ghaliz Dam), diluted bile 
(Raqeeq Safra) or pure bile (Khalis safra) 
suppurated Phlegm (Muta’affin Balgham) or 
suppurated blood & Phlegm both  
Fever with chills & rigor 
Pain & heaviness at the site 
of inflammation 
Irritation & restlessness  
Dysuria or Anuria   
7 Waram al-kulya Bārid  (Chronic 
Nephritis) 
Predominance of Phlegm (Balgham) & Black 
bile (Sauda) 
Mild Fever  
Edema 
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 Pain & Heaviness at the site 
of inflammation  
8 Dubayala al-kulya (Renal Abscess) 
 
Accumulation of pus within the inflamed 
kidney, turns into renal abscess  
Fever with chills & rigor  
Severe heaviness at the site 
of abscess  
Viscid and precipitated 
urine 
Pus discharge in the urine    
9 Quruh al-kulya (Renal ulcers) 
 
Passing of any irritable matter like acute 
bilious or salty humor, calculus through 
kidney  
Due to any injury and abrasion 
Boil 
Pain without  heaviness at 
renal angel   
Presence of pus, blood and 
dead tissue in the urine  
10  Jarab al-kulya (Renal irritability) 
 
Excessive used of that things which increases 
the hotness of blood or production of saline 
bile or phlegm increases 
Pain with irritation in 
lumber region 
Burning micturition 
Presence of pus & mucoid 
casts in the urine 
 
Modern Concepts of Kidney Diseases: 
“A heterogeneous group of disorders which affected the 
kidney structure and its functions known as kidney disease. 
Now a days, it is accepted that even minor abnormalities in 
measures of kidney structure and function are related with 
higher risk for other organ systems as well as mortality, all 
of which happen far more frequently than kidney failure. 
Kidney disease differs from the diseases of other organ 
systems, these diseases habitually “quiet “or sometimes 
having limited symptoms. The symptoms of renal diseases 
remains often nonspecific and until late in the course of 
disease. Thus, there are few kidney-specific “clinical events,” 
which results in a dependence on laboratory procedures to 
define the major clinical syndromes, so documentation or 
implication of the duration of abnormalities in laboratory 
measures are suggested the duration of kidney disease. 
  
Principles for the Definitions of Kidney Diseases and Disorders (18), (19) 
Disease/Disorder Functional criteria Structural Criteria 
Acute kidney Injury (AKI) Increase in S.Cr by 50% within 7 d, or increase in S.Cr by 0.3 
mg/dL within 2 d, or oliguria 
No criteria 
Chronic Kidney Disease (CKD) GFR < 60 mL/min for >3 mo. Kidney damage for >3 mo. 
Acute Kidney Injury (AKD) AKI, or GFR <60 mL/min/1.73 m2 for >3 mo. or decrease in 
GFR by ≥ 35% or increase in S.Cr by >50% for < 3 mo. 
Kidney damage for <3 mo. 
No known kidney disease (NKD) GFR ≥60 mL/min/1.73 m2 , stable S.Cr No damage 
 
      The following most common Kidney disorders and 
include (20) (19) 
 Acute kidney injury (AKI) or Acute renal failure (ARF) 
 Nephritic syndrome  
 Nephrotic syndrome 
 Tubulointerstitial disease 
 Vascular disease of the kidney 
 Papillary necrosis 
 Chronic kidney disease (CKD) 
Nephrotoxicity:  
Kidneys are performed many physiological functions of the 
body such as protection of homeostasis as well as regulation 
of extracellular atmosphere for example detoxification and 
elimination of toxic substances (metabolites) and 
therapeutic agents, these functions are more challenging task 
for the kidney, that’s why kidneys are the most important 
passage for the entry of any exogenous toxicant into human 
body. Nephrotoxicity occurs when kidney-specific 
detoxification and excretion do not work properly due to the 
damage or destruction of kidney function by exogenous or 
endogenous toxicants (effect of toxic chemicals or drugs) 
(13), (14). Nephrotoxins differ in their chemical structure, 
having different cellular targets and mechanism of cellular 
injury within the kidney and all of them produce varying 
degree of kidney damage. 
There are many drugs which are responsible for impairment 
of kidney functions & leads to renal perfusion or direct 
nephrotoxicity including antibiotics such as aminoglycoside, 
vancomycine, antifungal such as amphotericine B, 
immunomodulators such as calcineurin inhibitors, 
chemotherapeutic agents, cyclosporine, tacrolimus etc. 
Kidney injury can also occurs within days of initiating 
therapy with antihypertensive drugs such as ACE inhibitors, 
β-blockers, NSAIDS / selective COX-2 inhibitors, Cocaine, 
occupational toxins (21), (22). Approximately 20 % of 
hospitalized and non-hospitalized cases are suffering from 
acute renal failure (ARF) due to drug induced nephrotoxicity 
(23), (24), (25). The prevalence of drug-induced 
nephrotoxicity may be 66 percent high in the older adults 
(26). 
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Mechanisms of actions of drug induced nephrotoxicity:  
Drug induced nephrotoxicity can be explained by the 
following different pathogenic mechanism such as (27), (28).  
 Changed intra-glomerular hemodynamics,  
 Tubular cell toxicity,  
 Inflammation,  
 Crystal nephropathy,  
 Rhabdomyolysis, 
 Thrombotic microangiopathy
 
 
I. Changed intra-glomerular hemodynamics: The pathogenic mechanism of changed by the following flow chart; 
Anti-prostaglandin drugs       Anti-angiotensin-II 
 
 
Interfere with autoregulation of glomerular pressure 
 
Vasoconstriction 
 
Decreased blood flow 
 
Ischemic injury 
 
Decreased GFR 
 Nephrotoxic Drugs: NSAIDs, ACE Inhibitors, Cyclosporine, Tacrolimus (29), 
II. Tubular cell toxicity: The following flow chart explained the pathogenic mechanism of tubular cell toxicity; (30), (31) 
Nephrotoxic drug (Amphotericin B,antiretrovirals) 
 
Impairing mitochondrial function 
 
Interfering with tubular transport, 
 
Increasing oxidative stress or free radicals formation 
 
Tubular cell Toxicity 
 Nephrotoxic drugs: Antimicrobials, Amphotericin B, Beta-lactam antibiotics, Rifampicin, Adefovir, Cidofovir, and 
Contrast dye, Zoledronate (32), (33), (34), (35), (31), (36) 
III. Crystal nephropathy: Nephrotoxic drugs caused renal impairment by the production of urine insoluble crystals within 
the distal tubular lumen explained following flow chart (31), 
Urine insoluble Crystal’s production 
 
Precipitations of crystals (within the distal tubular lumen) 
 
Obstruction in urine flow 
 
Production of an interstitial reaction 
 
Renal impairment 
 
Crystal nephropathy 
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 Nephrotoxic Drugs: Foscornet, Methotrexate, Triamterene, Ganciclovir (35), (31), (37). 
IV. Rhabdomyolysis: It is the condition in which rapidly damaged & break down of skeletal muscles tissue, these damaged 
skeletal muscles cells such as myoglobin released into bloodstream and causes kidney injury. The pathogenic mechanism 
explained through following flow chart; (38)   
Skeletal muscle injury 
 
Lysis of the myocyte 
 
Releasing intracellular contents (myoglobin and creatine kinase) into the plasma. 
 
Renal injury 
(Direct renal toxicity, tubular obstruction, and modifications in GFR.) 
  
 Nephrotoxic drugs: Amitryptiline, Diphenhydramine, Doxylamine, Benzodiazepines, Statins, Methodone (39), (38) 
V. Thrombolytic Microangiopathy:  Thrombolytic microangiopathy is due to formation of thrombi in the microcirculation 
which leads to renal injury, following flow chart described pathogenic mechanism of thrombolytic microangiopathy (40) 
Formation of thrombus in the microcirculation 
 
Immune-mediated reaction 
 
Direct endothelial toxicity 
 Nephrotoxic drugs: Cyclosporin, Clopidogrel, 
Mitomycin C, Quinine (41), (40) 
VI. Inflammation: Inflammatory changes occurs mostly in 
the glomerulus, renal tubular cells, and the 
surrounding interstitium due to nephrotoxic drugs & 
fibrosis and renal scarring takes place. 
Glomerulonephritis is an inflammatory condition 
caused primarily by immune mechanisms and is often 
associated with proteinuria in the nephrotic range 
(35). 
 Nephrotoxic drugs: Allopurinol, Aspirin 
Acetaminophen, Acyclovir, antibiotics, Beta-lactam, 
Chinese medicines Quinolones, Rifampicin, 
Sulfonamides, Cisplatin, Loops & thiazide diuretics 
(35), (31), (42) 
Research scope of herbal medicine:  
Plants are very good for human health and used 
therapeutically in the various kidney disorders because 
presence of their chemical components and medicinal 
properties (43). Lots of herbs have been proven to be 
capable as Reno-protective agents but some of them are 
claimed to be Nephroprotective, there are so many 
researches available which proves the Nephroprotective 
effect of these herbal drugs such as  
1. Nephroprotective Action of Phoenix dactylifera.in 
Gentamicin-Induced Nephrotoxicity 
Aqueous extract of date flash has a prophylactic action on 
gentamicin induced nephrotoxicity in pretreated animals, 
proved by a significant decrease in the plasma 
concentrations of creatinine and urea & in an increase in the 
body weight of the animals during the treatment period. 
Aqueous extract of date flash also has a curative effect when 
it was given combined with gentamicin which proved by a 
significant decreased in increased biochemical parameters. 
Acute and chronic toxicity study also has been done by an 
oral administration of graded doses of the aqueous extracts 
of the date flesh and depths to male Wistar rats, proved that 
the given extract was safe for the animal (44). 
2. Nephroprotective Effect of Kabab Chini (Piper 
cubeba) in Gentamycin-Induced Nephrotoxicity 
The pre- and post-treated animal groups was taken powder 
of test drug in suspension form at 810 mg/kg and 1220 
mg/kg orally. The assessment parameters for 
nephroprotective effect are based on biochemical markers 
such as serum urea and creatinine levels as well as 
histopathological analysis of the treated kidney. Biochemical 
markers of renal function were found to be significantly 
lower in the pre-treated group in comparison the control 
group, while mild tubular damage shown in histological 
analysis. In the same way, there were a significant decrease 
in serum urea and creatinine levels in the post-treated 
animals in comparison to negative control group, moderate 
degree of tubular necrosis seen in the histopathological 
examination. So KC has a significant amount of 
nephroprotective activity which proved by the examination 
of biochemical markers of kidney function and the 
histopathological features pre-treated and post-treated 
groups (45). 
3. Nephroprotective Action Of Peucedanum Grande 
Against Cadmium Chloride Induced Renal Toxicity 
In Wistar Rat 
Nephroprotective effect of P. grande against CdCl2 induced 
nephrotoxicity was assessed by the estimation of 
biochemical markers, antioxidant enzyme activities and 
histopathological changes. Animals were taken pre-
treatment of P. grande at a dose of 60 and 120 mg/kg b.wt 
orally against the renal nephrotoxicity produced by CdCl2 at 
a dose of 3mg/kg b.wt. CdCl2 induced deteriorative effects 
were prevented by Pretreatment with P. grande, through a 
protective mechanism, which involved Improved 
deterioration i.e. increased oxidative stress as well as 
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histopathological changes i.e. damaged renal tissues against 
CdCl2 administration. BUN, creatinine significantly lower in 
pretreated rats with P. grande in comparison to that animals 
which getting only CdCl2. The present study concluded P. 
grande has potent nephroprotective activity through a 
protective mechanism & this activity of P. grande might be 
due to its free radical scavenging activity (46). 
4. Diuretic and nephroprotective effect of Jawarish 
Zarooni Sada—a polyherbal unani formulation 
 Ethanol and aqueous extracts of jawarish zarooni sada (JZS) 
at 300 mg each were examined as diuretic activity by 
calculating the total urine output over a period of 6 h in the 
present study. Sodium and potassium level in urine sample 
was also estimated. Nephrotoxicity was investigated by 
administration of JZS along with gentamicin at high dose (40 
mg/kg) and elevated biochemical markers such as urea and 
serum creatinine he study proved that JZS has significant 
diuretic and nephroprotective properties (47) 
5. Protective effects of ‘Khamira Abresham Hakim 
Arshad Wala’, a unani formulation against 
doxorubicin-induced cardiotoxicity and 
nephrotoxicity 
Doxorubicin produced a marked nephrotoxicity, as shown 
by in the elevation serum enzymes such as of AST, LDH, 
kidney biochemical markers i.e. BUN, creatinine, and, 
depletion in stress marker such as MDA, GSH level & catalase 
activity Khamira abresham Hakim Arshad wala showed 
nephroprotective effect against doxorubicin-induced 
nephrotoxicity, there was a significant enzymatic changes in 
serum as well as damaged renal tissues in pretreated group 
of animals. The results of present study reveals that the 
elevation & depletion in above serum enzymes, biochemical 
and stress markers as well renal damage were significantly 
(p < 0.01) improved after the treatment of Khamira Abraham 
Hakim Arshadwala (48) 
6. Nephroprotective Effect of Echinodorus 
macrophyllus Micheli on Gentamicin-Induced 
Nephrotoxicity in Rats 
Current study on “Nephroprotective Effect of Echinodorus 
macrophyllus Micheli on Gentamicin-Induced 
Nephrotoxicity in Rats” shown that gentamicin induced 
nephrotoxicity increased biochemical markers such as 
polyuria, decreased in GFR & morphological changes also. On 
treatment with extract Echinodorus macrophyllus Micheli 
(EM) along with gentamicin reversed all above alterated 
parameters & morphological changes were also not 
detected. EM extract also produced a dose-dependent 
decrease in urine elimination. So the study concluded that 
EM has nephroprotective potential & EM can used 
therapeutically an incidence of GM-induced acute kidney 
injury (49). 
7. Phytochemical, pharmacological evaluation 
of Morinda pubescens J.E.Sm. Bark extract for 
nephroprotective activity 
 Water extract Morinda pubescens J.E. Sm. (WEMp) of 
silymarin,  and its isolated ethyl acetate fraction compound 
(ISLTD mp-B) significantly increased the biochemical 
markers of kidney such as albumin, protein, body weight, 
and urine volume & decreased kidney serum creatinine, 
urea, uric acid, blood urea nitrogen, kidney weight with a 
significant reduction in gentamicin induced toxicity. The 
study also reveals that (WEMp) and (ISLTD mp-B) treated 
group increased urine output than normal which helped to  
dilutes the concentration of kidney function parameters 
such as  S. creatinine, urea, uric acid, and blood urea nitrogen 
. Thus, kidney’s toxins, increased biochemical markers or 
waste products are flushed out via the urine and reduced the 
chances or prevent the renal toxicity. The Reno protective 
activity of bark extracts may be due to the antioxidant 
activity, due to the existence of secondary metabolites i.e. 
tannins, flavonoids and phenolic compounds, etc. (50). 
8. Evaluation of Nephroprotective Activity of 
Ethanolic Extract of Annona reticulata in 
Gentamicin and Cisplatin Induced Nephrotoxicity 
in Rats 
 In the study “Evaluation of Nephroprotective Activity of 
Ethanolic Extract of Annona reticulata in Gentamicin and 
Cisplatin Induced Nephrotoxicity in Rats” toxicant group 
(2nd and 5th) gentamicin & cisplatin treated has severe 
nephrotoxicity evidence by an increment concentration of 
serum, urea, Creatinine, Uric acid, Total protein and Urine 
Urea, uric acid, creatinine in comparison to normal control 
(group 1). The increased biochemical parameters improved 
by the treatment of ethanolic extract of aerial parts of 
Annona reticulata & showed Nephroprotection because of 
presence of phyto chemical constituents (51). 
9. Evaluation for nephroprotective activity of ethanolic 
extract of Allium cepa Linn. In gentamicin-induced 
nephrotoxicity in rats  
Treatment with the A. cepa Linn. Has shown significant 
(p<0.01 and p<0.001) dose-dependent improvement in the 
body weight at the dose of 200 and 400 mg/kg and also 
shown significant improvement by protecting the kidney 
from the oxidative stress. It is also identified that treatment 
with A. cepa significantly lowered the level of serum 
creatinine, total protein when compared with the toxic group. 
Conclusion: Nephroprotective activity of EEAC treatment was 
found compared with the standard group (Vitamin E – 250 
mg/kg) and control group against the toxic control group 
animals in parameters including serum creatinine, total 
protein, kidney weights, and body weights. The 
histopathological studies were also evinced the protective 
effect of EEAC. (52). 
10. Nephroprotective Effect of Aqueous Extract of 
Pimpinella anisum in Gentamicin Induced 
Nephrotoxicity in Wistar Rat 
Co-administration of Pimpinella anisum extract with 
gentamicin decreased the following rise parameters such as 
serum urea, serum uric acid, and serum creatinine and blood 
urea nitrogen in a dose dependent manner. Gentamicin 
treated group shown nephrotoxicity proved by elevated 
serum urea, serum uric acid, serum creatinine and blood 
urea nitrogen (107.5±16.92mg/dl, 0.8±0.09 mg/dl, 
3.05±0.29 mg/dl, and 47.8±9.07 mg/dl) respectively in 
comparison to the saline treated groups. Gentamicin treated 
group also shows histopathological changes such as 
epithelial loss with deep granular degeneration in rats, while 
water extract of Pimpinella anisum decreased the severity of 
gentamicin-induced renal damage. So the study concluded, 
that water extract of Pimpinella anisum reveals 
nephroprotective effect in gentamicin induced renal damage 
(53). 
11. Nephroprotective Activity of Methanolic Extract of 
Lantana camara and Squash (Cucurbita pepo) on 
Cisplatin-Induced Nephrotoxicity in Rats and 
Identification of Certain Chemical Constituents of 
Lantana camara by HPLC-ESI-MS. 
Methanolic (defatted) extract of the two plants (Lantana 
camara and Cucurbita pepo) have nephroprotective effect on 
cisplatin-Induced nephrotoxicity in rats. Ethyl acetate and 
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butanolic derivative of methanolic extract of L. camara also 
had high nephroprotective activity. The study also revealed 
that the nephroprotective effect of these extract because of 
the presence secondary metabolites or plants phytochemical 
constituents such as phenolic acid derivatives, favonoids, 
phenylethanoids and Iridoids etc and phytochemicals 
analyses by the use of HPLC-ESI-MS technique (54). 
12. Nephroprotective Effect of Sonchus 
oleraceus Extract against Kidney Injury Induced by 
Ischemia-Reperfusion in Wistar Rats 
Sonchus oleraceus Extract (S.O.e) significantly reduced the 
higher level of kidney biochemical parameters such as urea 
nitrogen (BUN), creatinine, malondialdehyde (MDA), and 
pro-inflammatory cytokines & lowered the SOD level in 
Ischemia-Reperfusion (I/R) treated animal groups than the 
sham group. Tubular epithelial necrosis in the medulla and 
cortex were seen on histopathological examination in I/R 
treated group. While pretreatment with S.O.e & treatment in 
combination of S.O.e and I/R reduced the I/R induced 
increased renal biochemical parameters included BUN, 
creatinine, MDA, and proinflammatory cytokines induced, 
SOD as well as discontinuous necrosis in the medulla but no 
necrosis in the cortex on histopathological examinations. So 
the present study concluded that S.O.e has neither 
nephrotoxicity nor hepatotoxicity in spite of 
Nephroprotection pretreatment with S.O.e (55). 
13. Nephroprotective Effect of Camel Milk and 
Spirulina platensis in Gentamicin-Induced 
Nephrotoxicity in Rats 
Gentamicin treated animal group significantly showed 
increased levels of urea, creatinine and malondialdehyde, 
decreased level of glutathione (GSH) & extensive tubular 
necrosis present in histopathological examination. While 
extract of Camel Milk (CM) and Spirulina platensis (CP) and 
their combination (SPCM) treated animal group showed a 
significant improvement in these increased biochemical 
parameters, stress marker & histopathological changes (56).  
14. Phytochemical and Nephroprotective Activity of 
Eclipta prostrata against Gentamicin Induced 
Nephrotoxicity in Wistar Rats 
In the present study “Phytochemical and Nephroprotective 
Activity of Eclipta prostrata against Gentamicin Induced 
Nephrotoxicity in Wistar Rats” showed a significant 
nephrotoxicity in nephrotoxic group (Group II) by increased 
in S. urea, S. creatinine, and S. uric acid, BUN & kidney 
weight, while a major reduction has been shown in all these 
parameters in extract treated group which compared with 
standard (Cystone) group (Group V). Preliminary 
phytochemical screening of leaves of Eclipta prostrata 
reveals the presence of secondary metabolites such as 
terpenoids, glycosides, alkaloids, sterol, flavonoids, volatile 
oils and Saponins etc. (57). 
15. Acute nephroprotective and antioxidant activities 
of aqueous leaf extract of Plectranthus amboinicus 
(Roxb.) grown in Sri Lanka 
The current study has been shown that ADR produced 
nephrotoxicity by the elevated biochemical parameters such 
as S. in rats. The elevated S. creatinine level significantly 
decreased after treatment with aqueous extract of leaf of P. 
ambonicus (400 mg/kg body wt.) in comparison to control 
group. Glomerular and tubular functions of the kidney was 
measured by the β2 -microglobulin. Concentration of β2 -
microglobulin increased 50% in the control (nephrotoxic) 
group rats in comparison to the control group (healthy) 
(p0.05). The results of the study concluded that, P. 
ambonicus is reduced very fast the raised level of β2 –
microglobulin in the comparison & extract of plant leaf also 
reduced the increased levels of S. Albumin, total protein as 
compared to standard drug, proved nephroprotectivity of 
the leaf extract of P. amboinicus against ADR induced 
nephrotoxicity (58). 
16. Antioxidant and nephroprotection activities of 
Combretum micranthum: A phytochemical, in-vitro 
and exvivo studies 
End stage renal disease is a most common & serious 
complications of diabetic nephropathy. A significant dose 
dependent inhibition (P < 0.001) was found in lipid 
peroxidation induced by ferric chloride-ascorbic acid after 
treatment with CM extract. Human embryonic kidney cell 
(HEK-293) was used as in-vitro model for glucose induced 
toxicity for diabetic nephropathy in this study. The present 
study revealed that a significant morphological changes such 
as cell shrinkage, rounded cell shape and cytoplasmic 
vacuolation after taking the high glucose (100 mM) for 72 h, 
but the cell viability (10 to 23%) improved after taking 
treatment with 10 and 25 mg/ mL CM extract in comparison 
to high glucose control. The results of study proved that C. 
micranthum has potent antioxidant and nephroprotective 
activity (59). 
17. Nephroprotective activity of Combretum 
micranthum G. Don in cisplatin induced 
nephrotoxicity in rats: In-vitro, in-vivo and in-silico 
experiments 
Recent study on “Nephroprotective activity of Combretum 
micranthum G. Don in cisplatin induced nephrotoxicity in 
rats: In-vitro, in-vivo and in-silico experiments” reveals that 
Cisplatin produced a significant increase in cell death with 
changes in normal cellular morphology in HEK-293 cells. 
The study also revealed that CP and CM extract treated HEK-
293 cells shows a significant improvement in cell growth 
which indicate CM-extract has high cytoprotective activity in 
comparison to CP extract while CP-treated rats showed a 
characteristic clinical and pathological symptoms i.e. 
increased relative kidney weight, altered kidney function 
parameters such as creatinine, urea, uric acid, total  
protein, albumin and electrolytes against cisplatin induced 
cytotoxicity, hence  proved that CM extract contain 
Nephroprotective activity (60) 
Conclusions:  
The above review concludes that herbal drugs are very 
useful for kidney health. It is  mentioned in classical Unani 
literature that various single as well as compound 
formulations  are used extensively as diuretics (Mudir e 
baul), kidney and bladder tonics ( Muqawwi e Gurda wa 
Masana) and lithotripsic (mufattit hisaat) since ages. A 
number of researches has been performed  in this field but  
further  validation  with proper pre-clinical & clinical trials 
are needed so  the herbal  formulations as well as the single 
drugs could be accepted globally and  help the mankind  
with least adverse effects in various renal disorders. 
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